Inspire Medical Systems Cash on Hand 2017-2024 | INSP
Inspire Medical Systems cash on hand from 2017 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Inspire Medical Systems cash on hand for the quarter ending December 31, 2024 was $0.446B, a 3.22% decline year-over-year.
- Inspire Medical Systems cash on hand for 2024 was $0.446B, a 3.22% decline from 2023.
- Inspire Medical Systems cash on hand for 2023 was $0.46B, a 1.99% increase from 2022.
- Inspire Medical Systems cash on hand for 2022 was $0.451B, a 110.48% increase from 2021.
| Inspire Medical Systems Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $446 |
| 2023 | $460 |
| 2022 | $451 |
| 2021 | $214 |
| 2020 | $234 |
| 2019 | $149 |
| 2018 | $188 |
| 2017 | $16 |
| 2016 | $ |
| Inspire Medical Systems Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-12-31 | $446 |
| 2024-09-30 | $411 |
| 2024-06-30 | $440 |
| 2024-03-31 | $441 |
| 2023-12-31 | $460 |
| 2023-09-30 | $464 |
| 2023-06-30 | $467 |
| 2023-03-31 | $452 |
| 2022-12-31 | $451 |
| 2022-09-30 | $428 |
| 2022-06-30 | $196 |
| 2022-03-31 | $203 |
| 2021-12-31 | $214 |
| 2021-09-30 | $210 |
| 2021-06-30 | $208 |
| 2021-03-31 | $226 |
| 2020-12-31 | $234 |
| 2020-09-30 | $235 |
| 2020-06-30 | $243 |
| 2020-03-31 | $136 |
| 2019-12-31 | $149 |
| 2019-09-30 | $152 |
| 2019-06-30 | $159 |
| 2019-03-31 | $177 |
| 2018-12-31 | $188 |
| 2018-09-30 | $120 |
| 2018-06-30 | $124 |
| 2018-03-31 | $18 |
| 2017-12-31 | $16 |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.532B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.709B | 54.09 |
| Hims & Hers Health (HIMS) | United States | $11.210B | 183.25 |
| Tempus AI (TEM) | United States | $10.954B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.734B | 0.00 |
| Privia Health (PRVA) | United States | $2.941B | 245.10 |
| Enovis (ENOV) | United States | $2.475B | 16.49 |
| Clover Health Investments (CLOV) | United States | $2.095B | 0.00 |
| Azenta (AZTA) | United States | $2.083B | 96.98 |
| Omnicell (OMCL) | United States | $1.845B | 40.23 |
| Schrodinger (SDGR) | United States | $1.580B | 0.00 |
| Phreesia (PHR) | United States | $1.577B | 0.00 |
| 10x Genomics (TXG) | United States | $1.381B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.859B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.512B | 0.00 |
| Standard BioTools (LAB) | United States | $0.495B | 0.00 |
| Talkspace (TALK) | United States | $0.481B | 285.00 |
| TruBridge (TBRG) | United States | $0.423B | 123.26 |
| Nyxoah SA (NYXH) | Belgium | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.352B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.305B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.257B | 0.00 |
| American Well (AMWL) | United States | $0.174B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.085B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.072B | 0.00 |
| CareCloud (CCLD) | United States | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |